- Home
- Publications
- Publication Search
- Publication Details
Title
Trial Watch
Authors
Keywords
-
Journal
OncoImmunology
Volume 3, Issue 6, Pages e29179
Publisher
Informa UK Limited
Online
2014-05-16
DOI
10.4161/onci.29179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Immune Factors Regulating Antitumor Immunity Using Polymeric Vaccines with Multiple Adjuvants
- (2014) Omar A. Ali et al. CANCER RESEARCH
- Anti-interleukin-10R1 monoclonal antibody in combination with bacillus Calmette-Guérin is protective against bladder cancer metastasis in a murine orthotopic tumour model and demonstrates systemic specific anti-tumour immunity
- (2014) M. R. Newton et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation
- (2014) Lotte Spel et al. OncoImmunology
- The anticancer effects of HDAC inhibitors require the immune system
- (2014) Alison C West et al. OncoImmunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Trial Watch
- (2014) Erika Vacchelli et al. OncoImmunology
- A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma
- (2013) Thomas E. Witzig et al. AMERICAN JOURNAL OF HEMATOLOGY
- A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer
- (2013) Michael A. Morse et al. ANNALS OF SURGERY
- Anti-tumor Efficacy of a Hepatocellular Carcinoma Vaccine Based on Dendritic Cells Combined with Tumor-derived Autophagosomes in Murine Models
- (2013) Shu Su et al. Asian Pacific Journal of Cancer Prevention
- Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study
- (2013) Alexa J Resler et al. BMC CANCER
- Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer
- (2013) Chandra P Belani et al. CANCER BIOLOGY & THERAPY
- Adjuvants That Improve the Ratio of Antigen-Specific Effector to Regulatory T Cells Enhance Tumor Immunity
- (2013) R. Perret et al. CANCER RESEARCH
- Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
- (2013) T Yamazaki et al. CELL DEATH AND DIFFERENTIATION
- Perioperative Influenza Vaccination Reduces Postoperative Metastatic Disease by Reversing Surgery-Induced Dysfunction in Natural Killer Cells
- (2013) L.-H. Tai et al. CLINICAL CANCER RESEARCH
- Immunomodulatory Monoclonal Antibodies Combined with Peptide Vaccination Provide Potent Immunotherapy in an Aggressive Murine Neuroblastoma Model
- (2013) E. L. Williams et al. CLINICAL CANCER RESEARCH
- MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant
- (2013) Mark T. Orr et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Decreased functional response to Toll like receptor ligands in patients with oral cancer
- (2013) B. Paleja et al. HUMAN IMMUNOLOGY
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy
- (2013) Fernando Ulloa-Montoya et al. JOURNAL OF CLINICAL ONCOLOGY
- Decoding cell death signals in liver inflammation
- (2013) Catherine Brenner et al. JOURNAL OF HEPATOLOGY
- Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors
- (2013) Lisa L.R. Hartman et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Metabolic targets for cancer therapy
- (2013) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of TLR2, TLR4 and CD14 Genetic Polymorphisms in Gastric Carcinogenesis: A Case-Control Study and Meta-Analysis
- (2013) Natalia Castaño-Rodríguez et al. PLoS One
- Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis
- (2013) Tian-Hui Zou et al. TUMOR BIOLOGY
- TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses
- (2013) Christopher B. Fox et al. VACCINE
- Aldara activates TLR7-independent immune defence
- (2013) Anne Walter et al. Nature Communications
- Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses
- (2013) Mark Lebwohl et al. JAMA Dermatology
- Links between Toll-like receptor 4 and breast cancer
- (2013) Abubakr Ahmed et al. OncoImmunology
- MAGE-A3-specific anticancer immunotherapy in the clinical practice
- (2013) Vincent G. Brichard et al. OncoImmunology
- Myeloid derived suppressor cells
- (2013) Todd J. Waldron et al. OncoImmunology
- Signaling via MYD88 in the pancreatic tumor microenvironment
- (2013) Constantinos P. Zambirinis et al. OncoImmunology
- The Janus face of cyclophosphamide
- (2013) Giovanna Ziccheddu et al. OncoImmunology
- Inhibiting the inhibitors
- (2013) Domenico Mavilio et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
- (2013) Sandra Demaria et al. OncoImmunology
- TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+head and neck cancer cells
- (2013) Chwee Ming Lim et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- HDAC inhibitors and their potential applications to glioblastoma therapy
- (2013) Eleni Adamopoulou et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility
- (2012) Xie Junjie et al. BMC CANCER
- Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy
- (2012) Valérie Dutoit et al. BRAIN
- Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development
- (2012) George E. Theodoropoulos et al. BREAST
- Low-dose electron beam radiation and romidepsin therapy for symptomatic cutaneous T-cell lymphoma lesions
- (2012) O.E. Akilov et al. BRITISH JOURNAL OF DERMATOLOGY
- Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients
- (2012) Andrés Tittarelli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma
- (2012) Zhi-Hui Yang et al. CANCER SCIENCE
- The TLR4 gene polymorphisms and susceptibility to cancer: A systematic review and meta-analysis
- (2012) Kui Zhang et al. EUROPEAN JOURNAL OF CANCER
- Resiquimod, a topical drug for viral skin lesions and skin cancer
- (2012) Thomas Meyer et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure
- (2012) Pedro E. Marques et al. HEPATOLOGY
- Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer
- (2012) Macarena Guirado et al. HUMAN IMMUNOLOGY
- Toll-like Receptor 11 (TLR11) PreventsSalmonellaPenetration into the Murine Peyer Patches
- (2012) Zhongcheng Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combined TLR Stimulation With Pam3Cys and Poly I
- (2012) So Nai Lim et al. JOURNAL OF IMMUNOTHERAPY
- Induction of Antitumor Immunity Ex Vivo Using Dendritic Cells Transduced With Fowl Pox Vector Expressing MUC1, CEA, and a Triad of Costimulatory Molecules (rF-PANVAC)
- (2012) Baldev Vasir et al. JOURNAL OF IMMUNOTHERAPY
- Association of Toll-Like Receptor 2 Polymorphisms with Papillary Thyroid Cancer and Clinicopathologic Features in a Korean Population
- (2012) Mi Kyeong Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Toll-Like Receptor 3 Expressing Tumor Parenchyma and Infiltrating Natural Killer Cells in Hepatocellular Carcinoma Patients
- (2012) Valerie Chew et al. JNCI-Journal of the National Cancer Institute
- Involvement of toll-like receptor 9 polymorphism in cervical cancer development
- (2012) Andrzej Roszak et al. MOLECULAR BIOLOGY REPORTS
- Inflammasomes in carcinogenesis and anticancer immune responses
- (2012) Laurence Zitvogel et al. NATURE IMMUNOLOGY
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondria: master regulators of danger signalling
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Ingenol Mebutate Gel for Actinic Keratosis
- (2012) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymorphism of the TLR4 Gene Reduces the Risk of Hepatitis C Virus-Induced Hepatocellular Carcinoma
- (2012) José A. Agúndez et al. ONCOLOGY
- TLR13 Recognizes Bacterial 23S rRNA Devoid of Erythromycin Resistance-Forming Modification
- (2012) M. Oldenburg et al. SCIENCE
- Structural Basis of TLR5-Flagellin Recognition and Signaling
- (2012) S.-i. Yoon et al. SCIENCE
- The Structure of the TLR5-Flagellin Complex: A New Mode of Pathogen Detection, Conserved Receptor Dimerization for Signaling
- (2012) J. Lu et al. Science Signaling
- Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cells
- (2012) Laura P. Schneider et al. VACCINE
- How imiquimod licenses plasmacytoid dendritic cells to kill tumors
- (2012) Martin Holcmann et al. OncoImmunology
- Sound efficacy of prophylactic HPV vaccination
- (2012) Matti Lehtinen et al. OncoImmunology
- Blocking IL-10 enhances bacillus Calmette-Guérin induced T helper Type 1 immune responses and anti-bladder cancer immunity
- (2012) Yi Luo OncoImmunology
- IRF-1 is critical for IFNγ mediated immune surveillance
- (2012) Antje Ksienzyk et al. OncoImmunology
- Systemic cancer immunotherapy with Toll-like receptor 7 agonists
- (2012) Christian Hotz et al. OncoImmunology
- The role of innate immune signals in antitumor immunity
- (2012) Masahisa Jinushi OncoImmunology
- TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis
- (2012) Tsukasa Seya et al. OncoImmunology
- NY-ESO-1 expression in sarcomas
- (2012) Jin-Ping Lai et al. OncoImmunology
- Trial watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Autophagy-assisted antigen cross-presentation
- (2012) Yongxiang Yi et al. OncoImmunology
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
- (2012) Erika Vacchelli et al. OncoImmunology
- The IRF family of transcription factors
- (2012) Hideyuki Yanai et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo
- (2011) C. M. Hennies et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer
- (2011) M. Mohebtash et al. CLINICAL CANCER RESEARCH
- Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy
- (2011) Y. Li et al. CLINICAL CANCER RESEARCH
- Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism
- (2011) C. G. Twitty et al. CLINICAL CANCER RESEARCH
- The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma
- (2011) A Carvalho et al. GENES AND IMMUNITY
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C
- (2011) Hans-Dieter Nischalke et al. INTERNATIONAL JOURNAL OF CANCER
- Absence of MyD88 Results in Enhanced TLR3-Dependent Phosphorylation of IRF3 and Increased IFN- and RANTES Production
- (2011) J. Siednienko et al. JOURNAL OF IMMUNOLOGY
- Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses
- (2011) I. Jolanda M. de Vries et al. MOLECULAR IMMUNOLOGY
- Association of Inherited Variation in Toll-Like Receptor Genes with Malignant Melanoma Susceptibility and Survival
- (2011) Andreas Gast et al. PLoS One
- Sequence variants of toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men
- (2011) Hae Jong Kim et al. WORLD JOURNAL OF UROLOGY
- Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
- (2010) G. Schreibelt et al. BLOOD
- Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
- (2010) S. A. Grossman et al. CLINICAL CANCER RESEARCH
- Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma
- (2010) Frederick Lansigan et al. DRUGS
- TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like
- (2010) Jakub Siednienko et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
- (2010) Sara M. Mangsbo et al. JOURNAL OF IMMUNOTHERAPY
- Circulating mitochondrial DAMPs cause inflammatory responses to injury
- (2010) Qin Zhang et al. NATURE
- The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells
- (2010) Karin Loser et al. NATURE MEDICINE
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer
- (2010) Ivan Hirsch et al. TRENDS IN IMMUNOLOGY
- Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
- (2009) M. A. Curran et al. CANCER RESEARCH
- The antiviral activity of toll-like receptor 7 and 7/8 agonists
- (2009) R.L. Miller et al. DRUG NEWS & PERSPECTIVES
- Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate–gene association study
- (2009) Vassiliki Mollaki et al. JOURNAL OF HUMAN GENETICS
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Advances in saponin-based adjuvants
- (2009) Hong-Xiang Sun et al. VACCINE
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
- Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
- (2008) L. Liu et al. SCIENCE
- Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
- (2008) Pierre Vandepapelière et al. VACCINE
- Anti-tumor effect of DNA-based vaccination and dSLIM immunomodulatory molecules in mice with Ph+ acute lymphoblastic leukaemia
- (2008) Joachim Köchling et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started